Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > One more thing ......
View:
Post by fatboy92 on Dec 15, 2022 2:45am

One more thing ......

I guess this was one of those hockey stick revenue or liquidation events that we have heard from past and current CEO 's. I didn’t realize it would be for a 75% loss 
SEC where are you?
Comment by narmac on Dec 15, 2022 6:02am
,,,,,I wonder just what Midatech gains overall in this so called merger,,,,,buy out,,or what ever dogs breakfast you can call it?,,,,seems they are not the designer of all,,,it looks like the reverse splitting has them in similar market cap decay these past years,,,,,looks more like a round about corporate raid taking place under a different name! I do think Midatech is a much more aggresive ...more  
Comment by narmac on Dec 15, 2022 6:56am
After reading the BTI December presentation for the second time it comes to mind that we have a potential timeline of activity which again seems to have little catalyst by way of hard data which would allow the market to move our stock price up over the coming 12+ months. There is no business model included to show the dilution we can expect to be carried out due to the desribed activity going ...more  
Comment by summers123 on Dec 15, 2022 2:14pm
$MTP #MTPH    The most imortant reason why $MTP  bought bioaf is because it is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB)
Comment by fuzzyjr on Dec 15, 2022 2:47pm
"The most imortant reason why $MTP  bought bioaf is because it is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB)" i agree, its just going to take even more time - yuk i know - could be 2-3 years for big hit but in the meantime & after the dust settles here we could easily be up 3-4 times from this level in 3-6 ...more  
Comment by prophetoffactz on Dec 15, 2022 8:27am
"A lot of ifs and known unknowns around this deal as is said. There also seems to be fingers in this pie which have an orchestrated advantage over both of the main parties involved. Havent we all noticed!" Cash is King currently. We've been in the worst biotech market in history, literally. 25% of US biotech was trading below the value of the cash on the balance sheet in recent ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities